- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Isis Pharmaceuticals Inc+ Add to Watchlist
ISIS:US67.7600 USD 0.5900 0.88%
As of 20:10:00 ET on 05/22/2015.
Company Profile for Isis Pharmaceuticals Inc (ISIS)
Isis Pharmaceuticals, Inc. discovers and develops novel human therapeutic compounds. The company currently has various compounds in clinical trials for a variety of diseases such as Crohn's disease, psoriasis, asthma, and cancer. Isis' broad medical chemistry and biology research programs support efforts in both antisense and small molecule drug delivery.
Isis Pharmaceuticals Inc
Key Executives for Isis Pharmaceuticals Inc (ISIS)
|Stanley T Crooke "Stan"Chairman/President/CEO/Founder||B Lynne ParshallCOO/Secretary|
|Sarah BoyceChief Business Officer||Elizabeth L HougenSenior VP:Finance/CFO|
|Patrick R O'NeilSenior VP:Legal/Gen Counsel||C Frank BennettSenior VP:Antisense Research|
|Richard S GearySenior VP:Development||Brett P MoniaSenior VP:Drug Discovery|
|D Wade WalkeVP:Investor Relations|